TRCT
BFRI icon

Tower Research Capital (TRC)’s Biofrontera BFRI Stock Holding History

Tower Research Capital (TRC)’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,539
Closed -$4.95K – 5205
2024
Q4 		$4.95K Buy
4,539
+4,263
+1,545% +$4.03K ﹤0.01% 4372
2024
Q3 		$367 Sell
276
-10,215
-97% -$11.7K ﹤0.01% 5359
2024
Q2 		$9.42K Buy
10,491
+8,586
+451% +$11.9K ﹤0.01% 4256
2024
Q1 		$2.93K Sell
1,905
-1,268
-40% -$1.76K ﹤0.01% 4962
2023
Q4 		$8.79K Buy
+3,173
New +$13.8K ﹤0.01% 4464
2023
Q3 		– Sell
-655
Closed -$6.82K – 5950
2023
Q2 		$6.82K Sell
655
-7
-1% -$74 ﹤0.01% 4656
2023
Q1 		$8K Buy
662
+450
+212% +$7.02K ﹤0.01% 4608
2022
Q4 		$4K Sell
212
-221
-51% -$4.51K ﹤0.01% 4978
2022
Q3 		$9K Buy
+433
New +$11.8K ﹤0.01% 4634
2022
Q1 		– Sell
-8
Closed -$1K – 6089
2021
Q4 		$1K Buy
+8
New +$876 ﹤0.01% 5786

Other funds holding BFRI

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s BFRI Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Biofrontera (BFRI) in Q1 2025, closing a stake of 4,539 shares — an estimated $4.95K sold.

Tower Research Capital (TRC) first reported a position in BFRI in Q4 2021 and held it in 10 quarters. The position peaked at $9.42K in Q2 2024. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Biofrontera position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,539 Biofrontera shares in Q1 2025, an estimated $4.95K.
  • Tower Research Capital (TRC) first reported a position in Biofrontera in Q4 2021 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Biofrontera position peaked at $9.42K in Q2 2024.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.